首页 > 市场调查报告书 > 医疗设备

体外诊断

乳房切片市场规模、份额和成长分析（按产品、适应症、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1904435

乳房切片市场规模、份额和成长分析（按产品、适应症、最终用户和地区划分）—2026-2033年产业预测

Breast Biopsy Market Size, Share, and Growth Analysis, By Product (Biopsy Needles, Core Needles), By Indication (Complex Cysts, Solid Mass), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，乳房切片市场规模将达到 9.988 亿美元，到 2025 年将成长至 10.827 亿美元，到 2033 年将成长至 20.6415 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.4%。

乳房切片检查市场是医疗产业中快速成长的细分市场，其成长主要受乳癌发病率上升和人们对早期检测重要性认识不断提高的推动。影像和切片检查技术的进步，以及对微创手术需求的日益增长，正在重塑市场格局。目前，切片检查方法多种多样，包括粗针穿刺切片检查、真空吸引切片检查、细针穿刺活检和外科手术，其中影像引导技术因其更高的准确性而显着应用。此外，切片检查设备的创新，包括自动化系统和携带式设备，正在提高效率和患者舒适度。目前，北美凭藉其完善的医疗保健基础设施引领市场，但随着医疗保健支出和意识的提高，新兴经济体预计将迎来显着成长。

乳房切片市场成长要素

推动乳房切片市场成长的主要因素是全球乳癌发生率的上升。作为最常见的癌症之一，不断增加的病例数凸显了早期发现和适当干预的重要性。人们对识别乳房异常的日益关注，导致对乳房活检的需求激增，而乳房切片对于准确诊断至关重要。随着医疗机构寻求有效策略来应对这一日益严重的健康问题，对可靠、准确的诊断技术的需求也显着促进了乳房切片市场的扩张。

限制乳房切片市场的因素

全球乳房切片市场面临的一大挑战是假阴性和假阳性结果的出现。乳房切片对于识别乳癌至关重要，但同时也存在结果不准确的风险。假阴性结果可能导致癌细胞漏诊，延误诊断。另一方面，假阳性结果可能会给患者带来不必要的压力、额外的检查，甚至侵入性手术。这些诊断准确性问题会削弱人们对乳房切片有效性的信心，并使医护人员和患者在选择合适的治疗方案时面临更复杂的决策流程。

乳房切片市场趋势

乳房切片领域的一个显着市场趋势是影像引导切片检查技术的日益普及。超音波引导、乳房X光摄影引导和磁振造影引导等切片检查因其能够更精准地定位可疑乳房病灶而广泛应用。这些技术应用先进的影像模式，在显着提高诊断准确性的同时，与传统方法相比具有微创性。即时影像的整合能够更清晰地显示病灶区域，从而提高诊断效率并减少重复检查的需求。这一趋势凸显了业界致力于提升乳房切片手术效率、病患舒适度和整体安全性的决心。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Hologic, Inc.（USA）
Danaher Corporation（USA）
Becton, Dickinson and Company（BD）（USA）
Argon Medical Devices（USA）
Merit Medical Systems（USA）
Menarini-Silicon Biosystems（Italy）
Guardant Health, Inc.（USA）
NeoGenomics（USA）
Sysmex Inostics（Germany）
Ethicon Endo-Surgery, Inc.（USA）
CR Bard, Inc.（USA）
Leica Biosystems Nussloch GmbH（Germany）
Encapsule Medical Devices LLC（USA）
Intact Medical Corporation（USA）
Galini SRL（Italy）
Cook Medical Incorporated（USA）
Medtronic plc（Ireland）
Devicor Medical Products, Inc.（USA）
Carestream Health, Inc.（USA）
Planmed Oy（Finland）

结论与建议

简介目录

Product Code: SQMIG35A2467

Breast Biopsy Market size was valued at USD 998.8 Million in 2024 and is poised to grow from USD 1082.7 Million in 2025 to USD 2064.15 Million by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The breast biopsy market is a rapidly expanding segment of the healthcare industry, driven by the rising incidence of breast cancer and increased awareness of the importance of early detection. Technological advancements in imaging and biopsy techniques, coupled with a preference for minimally invasive procedures, are shaping the landscape. Various biopsy methods such as core needle, vacuum-assisted, fine needle aspiration, and surgical techniques are being utilized, with a noticeable shift towards image-guided procedures that enhance accuracy. Moreover, innovations in biopsy devices, including automated systems and handheld options, are enhancing efficiency and patient comfort. While North America currently leads the market due to its robust healthcare infrastructure, significant growth is anticipated in emerging economies as healthcare expenditures rise and awareness increases.

Top-down and bottom-up approaches were used to estimate and validate the size of the Breast Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Breast Biopsy Market Segments Analysis

Global Breast Biopsy Market is segmented by product, indication, end user and region. Based on product, the market is segmented into biopsy needles, MRI guide biopsy systems, ultrasound guided breast biopsy system, vacuum assisted devices, guide wire and breast biopsy markers. Based on indication, the market is segmented into complex cysts, solid mass, suspicious solid mass and suspicious micro calcifications. Based on end user, the market is segmented into hospitals, specialty clinics and cancer research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Breast Biopsy Market

A major catalyst for the growth of the Breast Biopsy Market is the rising prevalence of breast cancer across the globe. As one of the most frequently diagnosed cancers, the increasing cases have drawn attention to the importance of early detection and timely intervention. This heightened focus on identifying breast abnormalities has led to a surge in demand for breast biopsy procedures, which are crucial for accurate diagnosis. The necessity for dependable and precise diagnostic methods has played a significant role in expanding the breast biopsy market, as healthcare providers seek to implement effective strategies for managing this growing health concern.

Restraints in the Breast Biopsy Market

A significant challenge facing the global breast biopsy market is the occurrence of false-negative and false-positive results. While breast biopsies are essential for identifying breast cancer, there is a risk of inaccurate outcomes. False-negative results can lead to undetected cancerous cells, resulting in delayed diagnoses, while false-positive outcomes may subject patients to undue stress, extra testing, and even invasive procedures. These issues regarding diagnostic precision can diminish trust in the effectiveness of breast biopsy methods, complicating the decision-making process for both healthcare providers and patients in determining appropriate treatment options.

Market Trends of the Breast Biopsy Market

A prominent market trend within the breast biopsy sector is the escalating preference for image-guided biopsy techniques. Technologies such as ultrasound-guided, mammography-guided, and MRI-guided biopsies have garnered widespread acceptance due to their ability to enhance the precision of targeting suspicious breast lesions. By leveraging advanced imaging methods, these techniques significantly improve diagnostic accuracy while minimizing invasiveness compared to traditional approaches. The integration of real-time imaging allows for superior visualization of the area of concern, resulting in higher diagnostic yields and reducing the necessity for repeat procedures. This trend underscores the industry's commitment to advancing procedural efficiency, patient comfort, and overall safety in breast biopsy practices.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Breast Biopsy Market Size by Product & CAGR (2026-2033)

Market Overview
Biopsy Needles
- Core Needles
- Fine Aspiration Needles
Mri Guide Biopsy Systems
Ultrasound Guided Breast Biopsy System
- 2D Mammographic Ultrasonic Scanning Systems
- 3D B-Mode Mammographic Ultrasonic Scanning Systems
Vacuum Assisted Devices
Guide Wire
Breast Biopsy Markers

Global Breast Biopsy Market Size by Indication & CAGR (2026-2033)

Market Overview
Complex Cysts
Solid Mass
Suspicious Solid Mass
Suspicious Micro Calcifications

Global Breast Biopsy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Cancer Research Institutes

Global Breast Biopsy Market Size & CAGR (2026-2033)

North America (Product, Indication, End User)
- USA
- Canada
Europe (Product, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Argon Medical Devices (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Menarini-Silicon Biosystems (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guardant Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoGenomics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Inostics (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon Endo-Surgery, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C. R. Bard, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leica Biosystems Nussloch GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Encapsule Medical Devices LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intact Medical Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Galini SRL (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Incorporated (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devicor Medical Products, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carestream Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments